Abstract
AbstractTransfer of vaccine antibodies (Ab) from donors to recipients after transfusion of packed red blood cells (RBC) is supposed, thus affecting the recipients’ response to vaccinations. In this prospective study, SARS-CoV-2 IgG level in donors’ serum and RBC supernatant samples was assessed. Among 346 subjects, 280 were referred for hyperimmune plasma donation and 30 for whole blood donations. All units underwent pre-storage filtration, and residual plasma volume was 18±18 mL. The mean total IgG and IgM levels were 171.43 ± 48.79 and 11.43 ± 10.69 mg/dL respectively, with significant reduction after plasma depletion and filtration (IgG 5.86 ± 5.2 and IgM 1.43 ± 3.78, p < 0.05). Anti-COVID-19 Ab were identified in serum of 28/30 (93.5%) blood donors but were absent in all blood units. The mean value of anti-SARS-CoV-2 IgG level in donors’ serum samples and in RBC units was 8.80 S/C (range 0.01–23.4) and 0.11 (range 0.01–0.37) S/C, respectively (p<0.05). This study shows deplasmation and leukodepletion of RBC units ensured removal of IgG content and no red blood cell unit was reactive for anti-COVID-19 antibodies even from donors with high serum titre. These findings demonstrate that deplasmated and leukodepleted RBCs are not to be considered blood products containing substantial amounts of immune globulin, and differently from other blood derived-products containing Ab, transfusions with deplasmated and leukodepleted RBCs do not require delayed vaccinations and a revision of current recommendations is requested.
Funder
Università degli Studi della Campania Luigi Vanvitelli
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference30 articles.
1. Jones JM, Sapiano MRP, Mowla S, Bota D, Berger JJ, Basavaraju SV (2021) Has the trend of declining blood transfusions in the United States ended? Findings of the 2019 National Blood Collection and Utilization Survey. Transfusion 61:S1–S10
2. Petrini C (2017) Evaluation of EU legislation on blood: a bioethical point of view. J Blood Med 8:193–198
3. Casale M, Marsella M, Ammirabile M, Spasiano A, Costantini S, Cinque P, Ricchi P, Filosa A (2019) Predicting factors for liver iron overload at the first magnetic resonance in children with thalassaemia major. Blood Transfus-Italy 17(3):165–170
4. De Franceschi L, Lux C, Piel FB, Gianesin B, Bonetti F, Casale M, Graziadei G, Lisi R, Pinto V, Putti MC, Rigano P, Rosso R, Russo G, Spadola V, Pulvirenti C, Rizzi M, Mazzi F, Ruffo G, Forni GL (2019) Access to emergency departments for acute events and identification of sickle cell disease in refugees. Blood 133(19):2100–2103
5. Gianesin B, Pinto VM, Casale M, Corti P, Fidone C, Quintino S, Voi V, Forni GL (2020) Manual erythroexchange in sickle cell disease: multicenter validation of a protocol predictive of volume to exchange and hemoglobin values. Ann Hematol 99(9):2047–2055